The First & Only Conference Exclusively Focusing on ADC Payloads
Diversifying ADC Payloads as Warheads for Overcoming Tumor Resistance, With Optimised Efficacy, Potency, Mechanisms & Differentiated IP
Welcome to the 2nd ADC Payload Summit!
Discuss & Understand the Diversity of the Contemporary Payload Toolbox to Benchmark Your Warheads, Make Informed Payload-Selection Choices & Optimize Your Chemistry for Clinical Success
As the ADC landscape becomes more competitive, the limited availability of targets and antigens highlights the need to diversify payload modes of action to address cancers with high unmet needs. With novel payload categories such as degraders, RNA polymerase II inhibitors, immunomodulators, gene silences, and splice modulators entering the clinic, the industry must evaluate the benefits of these diverse mechanisms of action to develop the next block-buster ADC.
As part of the World ADC Series, the 2nd ADC Payload Summit returns to Boston to help you reimagine the medicinal chemistry of traditional cytotoxic payloads while scouting the next generation of ADC payload innovations.
At this summit, you’ll gain critical insights to:
CHARACTERIZE
the physiochemical properties of novel payloads
INNOVATE and OPTIMIZE
the medicinal chemistry of traditional payloads
BENCHMARK payload selection strategies tailored to indications
ENHANCE
structure-activity relationships by modifying payload-linker designs
Don’t miss this chance to stay ahead in a rapidly evolving field and
redefine what’s possible in ADC payload design
Top Testimonials:
"It’s exciting to see and learn about new and emerging ADC payloads!"
"Despite a long history of ADCs, the payloads at the clinical stage are mostly limited to a small number of cytotoxic molecules. Recently we have seen rapid expansion of payload classes used in preclinical ADC research. Research groups sharing experiences and learnings from each program will greatly benefit the field as we continue to explore various payload mechanism of action"
“Fantastic organisation, atmosphere and discussions”
“A variety of different payload-based topics were discussed which provided a well-rounded symposium”
“This was a highly specialized meeting which focused on the latest developments of payloads targeting immunology-oncology space.”
Previously Attending Companies Include:
About World ADC Series
The World ADC team ploughs its collective energy in to sourcing the insights you need. We investigate the most challenging problems facing the industry; source the leading experts who have game-changing solutions; and distil this into accessible formats of information exchange – for you. From globally leading conferences to webinars and industry reports, whatever the information you need, World ADC can offer you the insights you need to accelerate your ADC programs.
The value World ADC provides you is the power of insight and connections. Not artificial, and not short-lived. We nurture the right environments in which people can communicate problems and solutions; share novel data and forge networks across the industry that will make each of your endeavours more informed and more robust.
We share a common belief with the industry – that the potential of antibody drug conjugates is enormous. In the war against cancer, ADCs can be a game-changer and we know that the right insights and connections can sharpen the weapons that are in your arsenal.
Join us at the heart of the ADC community to improve your programmes and be part of the mission to develop better antibody drug conjugate drugs.
